ClearBridge LLC (Maryland)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,456,329
Closed -$5.48K 185
2018
Q2
$5.48K Sell
1,456,329
-1,197,935
-45% -$4.5K 0.09% 134
2018
Q1
$10.9M Sell
2,654,264
-38,480
-1% -$157K 0.24% 118
2017
Q4
$12.5M Buy
2,692,744
+1,087,120
+68% +$5.06M 0.26% 106
2017
Q3
$11.4M Buy
1,605,624
+134,580
+9% +$956K 0.25% 107
2017
Q2
$10.6M Buy
1,471,044
+168,404
+13% +$1.22M 0.23% 106
2017
Q1
$8.02M Buy
+1,302,640
New +$8.02M 0.17% 121